reviews investigating thoroughly all the metabolic eff ects of RBP 4. In this context, this article reviews the major aspects of the possible metabolic actions of RBP 4 and attempts to elucidate any resting confusion on this matter. The literature search was based on PubMed listings up to 1 August 2011. Type 2 Diabetes and Insulin Resistance ▼ Relationship between RBP 4 and clinical and laboratory parameters of insulin resistance Circulating RBP 4 and expression of RBP 4 mRNA in abdominal adipose tissue are increased in subjects with type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT), compared to subjects with normal glucose tolerance (NGT) [ 5-7 ]. However, circulating RBP 4 and synthesis rates of RBP 4 appear to be lower in type 1 diabetes mellitus (T1DM) compared to normal, nondiabetic individuals [ 8-11 ]. Furthermore, circulating RBP 4 is higher in women with gestational diabetes mellitus compared to healthy pregnant women [ 12 , 13 ]. Moreover, in nonobese, normoglycemic subjects with at least one fi rst-degree relative with T2DM, serum RBP 4 levels correlate inversely with the glucose disposal rate (GDR), which is a